NBIX - Neurocrine Biosciences Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
140.24 2.93 (2.09%) -0.1 (-0.07%) 0.0 (0.0%) 0.41 (0.29%) --- 2.93 (2.09%) --- ---

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
1.09
Diluted EPS:
1.06
Basic P/E:
131.3486
Diluted P/E:
135.066
RSI(14) 1m:
66.86
VWAP:
143.23
RVol:

Events

Period Kind Movement Occurred At

Related News